Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana
Roy Mwenechanya(University of Zambia), Michael P. Barrett(University of Glasgow), Nicholas J. Dickens(Wellcome Centre for Molecular Parasitology), Manikhandan Mudaliar(University of Glasgow), Julie Kovářová(Wellcome Centre for Molecular Parasitology), Galina I. Lepesheva(Vanderbilt University), Richard Burchmore(Wellcome Centre for Molecular Parasitology), Karl Burgess(University of Edinburgh), Pawel Herzyk(University of Glasgow), Isabel M. Vincent(Wellcome Centre for Molecular Parasitology), Terry Smith(University of St Andrews), Dong‐Hyun Kim(University of Nottingham), Darren J. Creek(Monash University), Stefan K. Weidt(University of Glasgow), Andrew W. Pountain(The University of Texas Health Science Center)
Cited by 63
Related Papers
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
|PLoS neglected tropical diseases|2017|990
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
|Proceedings of the National Academy of Sciences|2011|379
Human African trypanosomiasis: pharmacological re‐engagement with a neglected disease
|British Journal of Pharmacology|2007|323
MetExplore: a web server to link metabolomic experiments and genome-scale metabolic networks
|Nucleic Acids Research|2010|186
New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story
|Tropical Medicine and Infectious Disease|2020|149